Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
November 02, 2016Neil E. Kay, MD: Optimal approaches for the management of patients with deletion 17pWebcast: Lymphoma and Myeloma 2016: An International Congress on Hematologic Malignanacies22 minPlay
November 02, 2016John N. Allan, MD: Richter's syndrome: UpdateWebcast: Lymphoma and Myeloma 2016: An International Congress on Hematologic Malignanacies31 minPlay
November 02, 2016Swaminathan P. Iyer, MD: Novel agents in the pipeline for CLL and lymphomaWebcast: Lymphoma and Myeloma 2016: An International Congress on Hematologic Malignanacies15 minPlay
November 02, 2016Steven Treon, MD, PhD: New insights into the biology and treatment of Waldenström MacroglobulinemiaWebcast: Lymphoma and Myeloma 2016: An International Congress on Hematologic Malignanacies27 minPlay
November 02, 2016David Weinstock, MD: New Targets in peripheral T cell lymphomasWebcast: Lymphoma and Myeloma 2016: An International Congress on Hematologic Malignanacies19 minPlay
November 02, 2016Leandro Cerchietti, MD: Novel therapeutic strategies in B cell lymphomasWebcast: Lymphoma and Myeloma 2016: An International Congress on Hematologic Malignanacies25 minPlay
November 02, 2016Ann S. LaCasce, MD, MMSc: Debate: Limited state Hodgkin lymphoma patient who remains PET+ at the end of chemotherapy - Radiation therapyWebcast: Lymphoma and Myeloma 2016: An International Congress on Hematologic Malignanacies15 minPlay
November 02, 2016Koen van Besien, MD, PhD: Debate: Limited state Hodgkin lymphoma patient who remains PET+ at the end of chemotherapy - SCT-based therapyWebcast: Lymphoma and Myeloma 2016: An International Congress on Hematologic Malignanacies14 minPlay
November 02, 2016Alison Moskowitz, MD: Debate: Hodgkin lymphoma patient who relapses after autologous SCT - Serial novel agentsWebcast: Lymphoma and Myeloma 2016: An International Congress on Hematologic Malignanacies13 minPlay
November 02, 2016Robert W. Chen, MD: Debate: Hodgkin lymphoma patient who relapses after autologous SCT - Allogeneic SCTWebcast: Lymphoma and Myeloma 2016: An International Congress on Hematologic Malignanacies14 minPlay